2017 Innovation Grants - Professor John Hooper

The aim of this project is to lay the groundwork to develop a new radio-labelled antibody for improved imaging and treatment of pancreatic cancer. Using disease-relevant patient-derived cells grown as tumours in mice, and state-of-the-art imaging equipment, this project will evaluate the novel agent’s effectiveness for tumour staging and response to therapy and treatment of pancreatic cancer.